ArticleAntimicrobial agents and chemotherapy2013

Phase I, single-dose, dose-escalating study of inhaled dry powder capreomycin: a new approach to therapy of drug-resistant tuberculosis.

Ashwin S Dharmadhikari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.